VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $87,301 | -23.6% | 9,317 | +99.9% | 0.00% | – |
Q2 2023 | $114,334 | +22.2% | 4,661 | +15.9% | 0.00% | – |
Q1 2023 | $93,570 | -7.8% | 4,021 | +0.3% | 0.00% | – |
Q4 2022 | $101,443 | +407.2% | 4,008 | +274.2% | 0.00% | – |
Q3 2022 | $20,000 | -82.5% | 1,071 | -75.8% | 0.00% | – |
Q2 2022 | $114,000 | +11300.0% | 4,433 | +16950.0% | 0.00% | – |
Q3 2020 | $1,000 | -87.5% | 26 | -88.0% | 0.00% | – |
Q1 2020 | $8,000 | – | 216 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
Capital International Investors | 983,300 | $12,365,000 | 0.00% |
Blackstone Inc. | 35,000 | $440,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |